Journey Medical (DERM) Cash & Current Investments: 2020-2025
Historic Cash & Current Investments for Journey Medical (DERM) over the last 4 years, with Sep 2025 value amounting to $24.9 million.
- Journey Medical's Cash & Current Investments rose 10.88% to $24.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $86.7 million, marking a year-over-year decrease of 11.53%. This contributed to the annual value of $20.3 million for FY2024, which is 26.00% down from last year.
- Latest data reveals that Journey Medical reported Cash & Current Investments of $24.9 million as of Q3 2025, which was up 22.90% from $20.3 million recorded in Q2 2025.
- In the past 5 years, Journey Medical's Cash & Current Investments registered a high of $49.1 million during Q4 2021, and its lowest value of $17.0 million during Q2 2023.
- In the last 3 years, Journey Medical's Cash & Current Investments had a median value of $23.9 million in 2024 and averaged $22.9 million.
- Its Cash & Current Investments has fluctuated over the past 5 years, first soared by 495.44% in 2021, then tumbled by 55.43% in 2023.
- Over the past 5 years, Journey Medical's Cash & Current Investments (Quarterly) stood at $49.1 million in 2021, then tumbled by 34.82% to $32.0 million in 2022, then fell by 14.26% to $27.4 million in 2023, then dropped by 26.00% to $20.3 million in 2024, then climbed by 10.88% to $24.9 million in 2025.
- Its last three reported values are $24.9 million in Q3 2025, $20.3 million for Q2 2025, and $21.1 million during Q1 2025.